See also this year's filing and all EDGAR filings for this company.
PDF Report 0001100397_2015_Ayala_Pharmaceuticals_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001100397, Ayala Pharmaceuticals Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 20,494,061 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 2,767,945 |
| 2 | PropertyPlantAndEquipmentNet | 77,369 |
| 3 | remainder_Assets | 38,438 |
| 4 | LiabilitiesCurrent | 2,715,736 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 32,091 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 11,851,410 |
| 9 | ResearchAndDevelopmentExpense | 8,687,168 |
| 10 | remainder_Expenses | -2,351,627 |
| 11 | remainder_Revenues | 1,000,000 |
| 12 | remainder_NetIncome | 661,637 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 23,377,813 |
| 1 | Liabilities | 2,747,827 |
| 2 | Expenses | 18,186,951 |
| 3 | Revenues | 1,000,000 |
| 4 | StockholdersEquity | 20,629,986 |
| 5 | NetIncome | -16,525,314 |
| 6 | ComprehensiveNetIncome | -16,525,314 |
| 7 | BaseVar | 22,987,114 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.18 |
| 9 | EconomicCapitalRatio | 3.14 |
Edgar->Model Mapping
Feature Distribution
Change over Time
